IE · PI Dr. C. Nolan · activated
Patients
3
Active
2
Serious AEs
1
Open QA
1
Aged queries
0
Luna users
2
Studies & contracts
GAL-001: Adaptive Phase II in Refractory Melanoma
Phase II · study active · contract executed · 184000 USD
Safety — 2 AEs, 1 serious
serious
GAL001-004
Grade 3 Neutropenia — outcome: RECOVERED/RESOLVED; onset 2024-11-11 (study day 469); relationship: not assessed; serious criteria: hospitalization
QA findings (1 open)
open
major
Two informed consent forms missing investigator countersignature date.
Visits & payments
Nothing scheduled.
☾ Luna participants
Elif Demir
GAL001-004
granted
Sam Whitaker
GAL001-005
pending